214 related articles for article (PubMed ID: 16614248)
1. Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome.
Wlodarski MW; Gondek LP; Nearman ZP; Plasilova M; Kalaycio M; Hsi ED; Maciejewski JP
Blood; 2006 Oct; 108(8):2632-41. PubMed ID: 16614248
[TBL] [Abstract][Full Text] [Related]
2. Immune-mediated bone marrow failure syndromes of progenitor and stem cells: molecular analysis of cytotoxic T cell clones.
Maciejewski JP; O'Keefe C; Gondek L; Tiu R
Folia Histochem Cytobiol; 2007; 45(1):5-14. PubMed ID: 17378239
[TBL] [Abstract][Full Text] [Related]
3. Application of the molecular analysis of the T-cell receptor repertoire in the study of immune-mediated hematologic diseases.
Plasilova M; Risitano A; Maciejewski JP
Hematology; 2003 Jun; 8(3):173-81. PubMed ID: 12745651
[TBL] [Abstract][Full Text] [Related]
4. Shared and individual specificities of immunodominant cytotoxic T-cell clones in paroxysmal nocturnal hemoglobinuria as determined by molecular analysis.
Plasilova M; Risitano AM; O'Keefe CL; Rodriguez A; Wlodarski M; Young NS; Maciejewski J
Exp Hematol; 2004 Mar; 32(3):261-9. PubMed ID: 15003311
[TBL] [Abstract][Full Text] [Related]
5. Immune pathophysiology of aplastic anemia.
Maciejewski JP; Risitano A; Kook H; Zeng W; Chen G; Young NS
Int J Hematol; 2002 Aug; 76 Suppl 1():207-14. PubMed ID: 12430855
[TBL] [Abstract][Full Text] [Related]
6. In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing.
Risitano AM; Maciejewski JP; Green S; Plasilova M; Zeng W; Young NS
Lancet; 2004 Jul 24-30; 364(9431):355-64. PubMed ID: 15276395
[TBL] [Abstract][Full Text] [Related]
7. Large granular lymphocyte (LGL)-like clonal expansions in paroxysmal nocturnal hemoglobinuria (PNH) patients.
Risitano AM; Maciejewski JP; Muranski P; Wlodarski M; O'Keefe C; Sloand EM; Young NS
Leukemia; 2005 Feb; 19(2):217-22. PubMed ID: 15668701
[TBL] [Abstract][Full Text] [Related]
8. Response to Hypomethylating Agents in Myelodysplastic Syndrome Is Associated With Emergence of Novel TCR Clonotypes.
Abbas HA; Reville PK; Jiang X; Yang H; Reuben A; Im JS; Little L; Sinson JC; Chen K; Futreal A; Garcia-Manero G
Front Immunol; 2021; 12():659625. PubMed ID: 33912187
[TBL] [Abstract][Full Text] [Related]
9. N-RAS gene mutation in patients with aplastic anemia and aplastic anemia/ paroxysmal nocturnal hemoglobinuria during evolution to clonal disease.
Mortazavi Y; Tooze JA; Gordon-Smith EC; Rutherford TR
Blood; 2000 Jan; 95(2):646-50. PubMed ID: 10627475
[TBL] [Abstract][Full Text] [Related]
10. [Clonal hematopoiesis in aplastic anemia and paroxysmal nocturnal hemoglobinuria].
Makishima H
Rinsho Ketsueki; 2022; 63(9):1042-1045. PubMed ID: 36198527
[TBL] [Abstract][Full Text] [Related]
11. Molecular TCR diagnostics can be used to identify shared clonotypes after allogeneic hematopoietic stem cell transplantation.
O'keefe CL; Sobecks RM; Wlodarski M; Rodriguez A; Bell K; Kuczkowski E; Bolwell BJ; Maciejewski JP
Exp Hematol; 2004 Oct; 32(10):1010-22. PubMed ID: 15504556
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of TCR clonotypes in LGL: a clonal model for polyclonal responses.
O'Keefe CL; Plasilova M; Wlodarski M; Risitano AM; Rodriguez AR; Howe E; Young NS; Hsi E; Maciejewski JP
J Immunol; 2004 Feb; 172(3):1960-9. PubMed ID: 14734782
[TBL] [Abstract][Full Text] [Related]
13. Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes.
Ware RE; Pickens CV; DeCastro CM; Howard TA
Exp Hematol; 2001 Dec; 29(12):1403-9. PubMed ID: 11750098
[TBL] [Abstract][Full Text] [Related]
14. Somatic Mutations in Aplastic Anemia.
Mufti GJ; Marsh JCW
Hematol Oncol Clin North Am; 2018 Aug; 32(4):595-607. PubMed ID: 30047413
[TBL] [Abstract][Full Text] [Related]
15. Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia.
Kook H; Zeng W; Guibin C; Kirby M; Young NS; Maciejewski JP
Exp Hematol; 2001 Nov; 29(11):1270-7. PubMed ID: 11698122
[TBL] [Abstract][Full Text] [Related]
16. Polyclonal hematopoiesis maintained in patients with bone marrow failure harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells.
Ishiyama K; Chuhjo T; Wang H; Yachie A; Omine M; Nakao S
Blood; 2003 Aug; 102(4):1211-6. PubMed ID: 12676778
[TBL] [Abstract][Full Text] [Related]
17. Impact of immunogenetic polymorphisms in bone marrow failure syndromes.
Serio B; Selleri C; Maciejewski JP
Mini Rev Med Chem; 2011 Jun; 11(6):544-52. PubMed ID: 21561401
[TBL] [Abstract][Full Text] [Related]
18. Deep sequencing and flow cytometric characterization of expanded effector memory CD8
Giudice V; Feng X; Lin Z; Hu W; Zhang F; Qiao W; Ibanez MDPF; Rios O; Young NS
Haematologica; 2018 May; 103(5):759-769. PubMed ID: 29419434
[TBL] [Abstract][Full Text] [Related]
19. Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.
Maciejewski JP; Follmann D; Nakamura R; Saunthararajah Y; Rivera CE; Simonis T; Brown KE; Barrett JA; Young NS
Blood; 2001 Dec; 98(13):3513-9. PubMed ID: 11739151
[TBL] [Abstract][Full Text] [Related]
20. Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells.
Feng X; Chuhjo T; Sugimori C; Kotani T; Lu X; Takami A; Takamatsu H; Yamazaki H; Nakao S
Blood; 2004 Oct; 104(8):2425-31. PubMed ID: 15217832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
